Opus Point Partners Management, LLC - Q1 2016 holdings

$129 Million is the total value of Opus Point Partners Management, LLC's 52 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was - .

 Value Shares↓ Weighting
IWM NewISHARES TRput$22,126,000200,000
+100.0%
17.10%
PFE NewPFIZER INC$3,260,000110,000
+100.0%
2.52%
ONCE NewSPARK THERAPEUTICS INC$930,00031,500
+100.0%
0.72%
SNR NewNEW SR INVT GROUP INC$927,00090,000
+100.0%
0.72%
RARE NewULTRAGENYX PHARMACEUTICAL IN$855,00013,500
+100.0%
0.66%
SDS NewPROSHARES TR$853,00045,000
+100.0%
0.66%
PSDV NewPSIVIDA CORP$482,000180,000
+100.0%
0.37%
LABU NewDIREXION SHS ETF TRsp biotch bl new$329,00011,988
+100.0%
0.25%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR/A filed 2016-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
METTLER-TOLEDO INTL CMN20Q3 20194.7%
ALNYLAM PHARMACEUTICALS, INC. CMN20Q3 20195.0%
VERTEX PHARMACEUTICALS INC CMN20Q3 20194.0%
ILLUMINA, INC. CMN20Q3 20194.4%
SEATTLE GENETICS, INC. CMN20Q3 20194.0%
ALEXION PHARMACEUTICALS INC CMN20Q3 20194.3%
INCYTE CORPORATION CMN20Q3 20194.4%
NEKTAR THERAPEUTICS CMN20Q3 20194.9%
REGENERON PHARMACEUTICALS20Q3 20193.8%
CELGENE CORPORATION CMN20Q3 20193.8%

View Opus Point Partners Management, LLC's complete holdings history.

Latest filings
TypeFiled
13F-HR2019-11-14
13F-HR2019-08-14
13F-HR2019-05-15
13F-HR2019-02-14
13F-HR2018-11-14
13F-HR2018-08-14
13F-HR2018-05-15
13F-HR2018-02-14
13F-HR/A2017-11-17
13F-HR2017-11-14

View Opus Point Partners Management, LLC's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported has been restated
  • The reported has been amended

Export Opus Point Partners Management, LLC's holdings